Lincoln National Corp Kodiak Sciences Inc. Transaction History
Lincoln National Corp
- $3.1 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding KOD
# of Institutions
108Shares Held
41.3MCall Options Held
10.9KPut Options Held
700-
Baker Bros. Advisors LP New York, NY17.3MShares$57.3 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$12.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$5.59 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.53MShares$5.07 Million0.04% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.33MShares$4.39 Million0.01% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $172M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...